Meyer Vitabiotics, a subsidiary of Vitabiotics Ltd, the UK’s leading vitamin company, has conducted a study revealing the potential of an antioxidant blend, Oligocare Forte Plus, to significantly improve male fertility. The research involved 300 Indian males with varying types and degrees of infertility and tested the effectiveness of the supplement containing a mix of multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. Results revealed a 75.76% increase in sperm count among males with a baseline sperm count of less than 5 million/ml.
Male infertility is a significant global concern, responsible for 20-30% of total cases. Existing treatment options, such as surgery, hormonal therapy, and drug therapy, are often costly, uncertain in their effectiveness, and come with potential side effects. Antioxidants have gained increasing interest among clinicians and researchers for boosting parameters of male fertility.
The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health. Antioxidants frequently prescribed for treating male infertility include vitamins E and C, carnitine, N-acetyl cysteine, selenium, and zinc.
Meyer Vitabiotics’ study offers a new perspective on male infertility treatment, showcasing the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to current options. The results provide valuable insights into the impact of antioxidant therapy on improving semen parameters and the DNA Fragmentation Index (DFI), highlighting the potential of multi-micronutrient therapy for addressing male infertility.